Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ: CMPS )

42.50 -0.33 (-0.77%)
Official Closing Price Updated: 7:15 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2 3 4 Next >
Hope on the Horizon: Psychedelics Offer Potential for Transforming Mental Health Treatments
From InvestorBrandNetwork
Hope on the Horizon: Psychedelics Offer Potential for Transforming Mental Health Treatments
NetworkNewsWire Editorial Coverage 
From PR Newswire
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
Welcome to theCannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock ... 
Tags MMEDF Small Cap PayPal Holdings
From Benzinga
Psychedelic Stocks Index Soared 27% On Monday
31 biopharmaceutical companies are now involved in the research and development of psychedelic compounds to treat mental health issues. 15 of them are constituents in the Psychedelic Stocks Index and... 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Growing Medical Support Helps Buoy Psychedelic Research
FinancialBuzz.com News Commentary 
From PR Newswire
Psychedelic Stocks Index Took Off Last Week, Gaining 35.3%
Updating the performance of the 15 stocks in our Psychedelic Stocks Index. 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Rotation Opportunity As Three Top Psychedelic Stocks Explode
With its first psychedelic-assisted treatment clinic preparing to open, Mind Cure Health is an undervalued rotation target. 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Why Psychedelic Drugs Market is Expected to See Overwhelming Growth in Coming Years
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Why Psychedelic Drugs Market is Expected to See Overwhelming Growth in Coming Years
- Financialnewsmedia.com News Commentary 
From PR Newswire
Big-Name Executives and Celebrities Open Up Opportunities for Retail Investors by Investing in Psychedelic Treatment as a Means of Addressing Mental Health Crisis
From GlobeNewswire News Releases
Big Financings Powering Future Profits In Psychedelic Stocks
$400 million in investment capital has flooded into psychedelic drug companies in just the last 10 weeks. Investors take note. 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Looking For Top Penny Stocks Right Now? 3 Psychedelic Stocks To Watch
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Understanding The Psilocybin Supply Chain: Every Production Method Explained
Psilocybin is known as the active compound in so-called “magic mushrooms”, yet most psilocybin used in clinical trials today ... 
Tags CaaMTech MYCOF Benzinga
From Benzinga
12 Healthcare Stocks Moving In Tuesday's After-Market Session
Gainers Compass Pathways (NASDAQ:CMPS) shares increased by 7.59% to $48.0 during Tuesday's after-market session. Trading volume ... 
Tags MBRX General NDRA
From Benzinga
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
Welcome to theCannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock ... 
Tags Cannabis APHA MindMed
From Benzinga
The Biotech Breakthrough Transforming Mental Health
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
The Biotech Breakthrough Transforming Mental Health
FN Media Group Presents GlobalInvestmentDaily.com Market Commentary 
From PR Newswire
Is Compass Pathways a Good Stock to Buy Now?
The company's fresh look at psychedelic drugs is attracting lots of attention. 
Tags CMPS Market News
From Motley Fool
64 Biggest Movers From Friday
Gainers SCWorx Corp. (NASDAQ: WORX) shares climbed 77.6% to close at $2.22 on Friday on more than 4x average volume. The ... 
Tags Movers TOUR SOL
From Benzinga
These 20 Psychedelic Stocks Went Up 37.4%, On Average, Last Week
The 20 stocks not included in the munKNEE Pure-Play Psychedelic Stock Index went up 37.4% last week. This article identifies, describes and tracks the performance of those "shroom" stocks divided into... 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Psychedelic Stocks Really Took Off Last Week
Thirty-one bio-pharmaceutical companies are now involved in the research and development of psychedelic compounds to treat mental health issues. 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
48 Stocks Moving In Friday's Mid-Day Session
Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 79.2% to $2.24 on more than 4x average volume. The company’s shares gained ... 
Tags ANIX BTBT Penny Stocks
From Benzinga
Scott St. Clair: The Art Of Managing Winning Stocks Making Powerful Moves
Scott St. Clair of MarketSmith joined the podcast this week to discuss the current market action. He also explained why patience and imagination are important for managing winning trades. Plus, we take... 
From Investor's Business Daily
Missed Out on Marijuana Stocks? Psychedelic Stocks Could Be the Next Big Thing
The market is in its early stage, and the players in the space could have a lot of room to run. 
Tags MMED/F CMPS Market News
From Motley Fool
Why An ATAI IPO Is Driving MindMed Stock
ATAI Life Sciences has announced its going public in Spring 2021. MindMed Inc has exploded on this news. Find out why the two events are connected. 
Tags Stocks / Equities Healthcare Pharma/Biotech
From Blogs - TalkMarkets
Psychedelic Drug Stock's Biggest Investor Closes $125 Million Funding Round
Atai Life Sciences, a company that backs Compass Pathways (CMPS) and other psychedelic drug developers, said Monday that it had closed a $125 million funding round, the latest infusion for an industry... 
From Investor's Business Daily
The New Psychedelic Stocks Index Declined 5.4% This Past Week
This article tracks the weekly performance of 11 of 31 stocks involved in the research and development of psychedelic compounds to treat mental health issues such as OCD, PTSD, opioid and alcohol... 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Psychedelics Transition from Experimental Treatment to Major Pharmaceutical Industry
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Psychedelics Transition from Experimental Treatment to Major Pharmaceutical Industry
FN Media Group Presents Microsmallcap.com Market Commentary 
From PR Newswire
Is Compass Pathways Stock a Buy?
Oregon just decriminalized the use of the psychedelic compound psilocybin. Could Compass Pathways, which is testing a synthetic form of the drug as a mental health therapy, be on the cusp of something... 
Tags CRLBF Market News CMPS
From Motley Fool
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.